Screening and Eligibility for DPP Clinical Guidelines Presentation: Screening & Eligibility Klamath Tribe.

Slides:



Advertisements
Similar presentations
2003 CDA Clinical Practice Guidelines
Advertisements

Standards of Medical Care in Diabetes—2012
Optimizing Diabetic Care in Residential Care
P REDICTION OF GESTATIONAL DIABETES MELLITUS BY MATERNAL FACTORS AND BIOMARKERS AT 11 TO 13 WEEKS.
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Choctaw Nation Diabetes Wellness Center
Glucose Tolerance Test Diabetes Mellitus Dr. David Gee FCSN Nutrition Assessment Laboratory.
Diabetes in Pregnancy Screening.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Demonstration Projects Core Elements Update July 28,
Diabetes Nhung H. Nguyen. Definition: “A metabolic disease in which the body’s inability to produce any or enough insulin causes elevated levels of glucose.
Screening for Prediabetes Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Technical Assistance Meeting.
Recruitment and Retention for Diabetes Prevention Carol Percy, RN, MS Shiprock DPPOS Program Coordinator Roz Barber Shiprock DPP Recruitment and Retention.
DR. TARIK Y. ZAMZAMI MD, CABOG, FICS ASSOCIATE PROFESSOR CONSULTANT OB/GYN
Diabetes Prevention Group Screening and Eligibility Core Elements Update May 2005.
Core Elements.  Recruitment Goals = 48 new participants each year  Recruitment for Intensive Activities 1. Recruitment Team 2. Team Meetings  Invitation.
Recruitment and Retention for CVD Risk Reduction Carol Percy, RN, MS Shiprock DPPOS Program Coordinator Mary Hoskin, RD, MS Phoenix DPPOS Program Coordinator.
Screening and Eligibility for DPP Clinical Guidelines.
The Diabetes Prevention Program 10 Year follow-up Long-term Follow-up to A Randomized Clinical Trial to Prevent Type 2 Diabetes in Persons at High Risk.
CVD Risk Reduction Group Screening and Eligibility Core Elements Draft July 2005.
SDPI Healthy Heart Project SDPI Competitive Grant Program Technical Assistance Meeting October 23-24, 2006 Tucson, AZ Core Elements: Recruitment and Screening.
2 hour OGTT for Healthy Heart Project REQUIRED for diagnosis of DM in individuals with a (+) Screening test REQUIRED for diagnosis of DM in individuals.
ADVICE. Advice Strongly advise adherence to diet and medication Smoking cessation, exercise, weight reduction Ensure diabetes education and advise Diabetes.
A medical test to determine the ability of an individual to maintain HOMEOSTASIS of Blood Glucose The most commonly performed version of the Test (OGTT)
I CAN Prevent Diabetes! Individuals and Communities Acting Now to Prevent Diabetes Recruitment Discussion 2012.
Oral Glucose Tolerance Test By: Dr. Beenish Zaki Date: 09/05/2012 Senior Instructor Department of Biochemistry.
Glucose and Cholesterol Screening for Pediatric Obesity A Training for CHDP Providers Prepared by: The CHDP Nutrition Subcommittee.
Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.
Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.
Prediabetes Burden.
Prediabetes Screening and Monitoring 1. Rationale for Prediabetes Screening Epidemiologic evidence suggests the complications of diabetes begin early.
M.G.S.D. The Gestational Diabetes Study in the Mediterranean Region Protocol C. Savona-Ventura Research Management Committee – M.G.S.D.
DIABETES 1 The Value of Screening: HbA1c as a Diagnostic Tool David Kendall, MD Chief Scientific and Medical Officer American Diabetes.
O Identify whether all patients in the practice population diagnosed with IFG have had a repeat fasting blood glucose (FBG) within the past 12months o.
Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?
Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.
Diagnosis of diabetes. Diabetic symptoms Diabetic symptoms + venous sample for : –Random venous ≥ 11.1 mmol/l ( ) –Fasting glucose > 7(
Oneida Community Health Nursing Department Disease Screening Form- updated 02/28/12 MLM Have you been screened for diabetes or high blood pressure beforeYESYESNO.
Pre-screening Tool: ADA Risk Test Given to patients by front desk at new patient appointments Administered at community events by DPP Staff Positive screening.
Tina Huang.  Aimed at people aged 40 – 74  Risk assessment and management programme to prevent or delay the onset of diabetes, heart and kidney disease.
Risk of Type 2 Diabetes and It’s Complications Along The Continuum of Fasting Plasma Glucose Gregory A. Nichols, PhD Collaborative Diabetes Education Conference.
GDM-DEFINITION Gestational Diabetes Mellitus (GDM) is defined as ‘carbohydrate intolerance with recognition or onset during pregnancy’, irrespective of.
Cook Island Presentation PSRH Conference Samoa Dr. May.
Screening for Type 1 & Type 2 Diabetes Key Messages In the absence of evidence for interventions to prevent or delay type 1 diabetes, screening for type.
Pre-diabetes: Risk Factors & Diagnosis Saoirse Ní Chuirrín DNS Caitriona Lordan Dietitian September 2015.
Diabetes mellitus “ Basic approach” Dr Sajith.V.S MBBS,MD (Gen Med )
Diabetes. Diabetes mellitus, or simply diabetes, is a group of metabolic diseases in which a person has high blood sugar, either because the body does.
Welcome to Class You made a great choice! To decide, to be a t the level of choice, is to take responsibility for your life and to be in control of your.
Gestational Diabetes Gestational Diabetes. Definition Any degree of glucose intolerance with onset or 1 st recognition during pregnancy. Any degree of.
Source:
Diabetes Mellitus Introduction to Diabetes Epidemiology.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
Epidemiology of Diabetes Mellitus. Diabetes mellitus is a group of diseases marked by high levels of blood glucose resulting from defects in insulin production,
Diabetes mellitus: Strategies for control Aznida Firzah Abdul Aziz MBBS MMed (Fam Med) Department of Family Medicine Faculty of Medicine Universiti Kebangsaan.
Table 1 Descriptive Variables __________________________________________________________________________________________ Variables M (SD) Min. Max. n*
A two stage screening process – the pre-diabetes pathway.
DIABETES CASE PRESENTATIONS 1 st - diagnosis. Case 1 Male, 24 yrs old Male, 24 yrs old Presents in the ER for nausea, vomiting, abdominal pain, shortness.
Screening for Diabetes in Pregnancy
بايو كمستري (م 3) / د . احمد الطويل
Diabetes- pregnancy, labour and the puerperium guideline
GLUCOSE TOLERANCE TEST (GTT)
A Study on Gestational Diabetes in Eastern India
Presenter : For : Dr. Dhananjay Gupta API-DSC 2016
Capacity Building for Prevention of Complication from Gestational Diabetes in Public health system, UP Dr Rajesh Jain Project Manager Diabetes Prevention.
Screening and Monitoring
Screening and Monitoring
Screening for Diabetes in Pregnancy
Prediabetes Burden.
GESTATIONAL DIABETES RISKS AND FUTURE. GESTATIONAL DIABETES RISKS AND FUTURE.
Diabetes and Pregnancy
Presentation transcript:

Screening and Eligibility for DPP Clinical Guidelines Presentation: Screening & Eligibility Klamath Tribe

Eligibility Impaired Fasting Glucose (IFG) = Impaired Glucose Tolerance (IGT)= Prediabetes Individuals eligible for SCREENING – follow Core Element guidelines

At Risk for Diabetes Family member with type 2 diabetes (parents or siblings with diabetes) Overweight –BMI ≥25 kg/m2 Age ≥ 35 Habitual inactivity (no regular physical activity, less than 30 minutes 3 times a week) Previous diagnosis of Prediabetes (IFG or IGT) Prior GDM or delivery of a baby weighing > 9 lbs History of Polycystic Ovarian Syndrome Any other component of Metabolic Syndrome (ATP III) * The clinical measures listed on these documents were used by the programs over the past 10 years and were current at their time of use. However, these example documents are not intended to serve as current clinical guidelines. Programs using these documents will need to ensure the clinical measures are current for their intended use.

Screening Remember – there will be many more individuals who are eligible for screening than are eligible for participation Exclude eligible individuals from participation in this project who have any of the exclusion diagnoses/conditions:

Exclusion Criteria –Current diagnosis of pregnancy (reconsider participation 6 weeks after delivery, suspend participation if becomes pregnant during project) –Active alcohol or substance abuse by provider judgment that would affect successful participation –End Stage Renal Disease on dialysis –Previous diagnosis of diabetes (not eligible for diabetes prevention) –Current diagnosis of cancer undergoing treatment that prohibits participation – provider judgment

Community Screening Do Random Blood Sugar (RBS) AND ADA Risk Test (+) Screening = RBS > 100 OR ADA Score ≥ 10 = Refer to Clinic/schedule for OGTT if agrees to participate (–) Screening = Provide education/information and offer f/u * The clinical measures listed on these documents were used by the programs over the past 10 years and were current at their time of use. However, these example documents are not intended to serve as current clinical guidelines. Programs using these documents will need to ensure the clinical measures are current for their intended use.

Clinic Screening 2 hour OGTT AND ADA Risk Test (if not already done) Do not use Fasting Blood Sugar (FBS) testing in place of 2 hr OGTT

2 hour OGTT Only 1 OGTT result necessary for diagnosis of Prediabetes If individual has a previous diagnosis of Prediabetes AND: 1. OGTT done < 6 months before baseline assessment = do a FBS to ensure not progressed to Diabetes 2. OGTT done > 6 months before baseline assessment = REPEAT 2 hour OGTT * The clinical measures listed on these documents were used by the programs over the past 10 years and were current at their time of use. However, these example documents are not intended to serve as current clinical guidelines. Programs using these documents will need to ensure the clinical measures are current for their intended use.

2 hour OGTT results NORMALPRE-DMDIABETES (presume) FBS< – 125  hr BS< – 199  200 One or more abnormal result in the Pre-diabetes range = Pre-diabetes * The clinical measures listed on these documents were used by the programs over the past 10 years and were current at their time of use. However, these example documents are not intended to serve as current clinical guidelines. Programs using these documents will need to ensure the clinical measures are current for their intended use.

Diagnosing Pre-diabetes Diagnosis must be made by a Licensed Independent Practitioner Notification of individual can be delegated to a clinical staff/project staff member – RN, RD, etc.